Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

AS2444697

AS2444697 is an orally active IRAK-4 inhibitor with an IC50 of 21 nM[1]. AS2444697 potently inhibits human and rat IRAK-4 activity. AS2444697 exhibits renoprotective effects through anti-inflammatory action[2].

Product Specifications

CAS Number

[1287665-60-4]

UNSPSC

12352005

Target

IRAK

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/as2444697.html

Purity

99.54

Solubility

DMSO : ≥ 12.5 mg/mL

Smiles

O=C(NC1=CN(C2CCOCC2)N=C1C(N)=O)C3=COC(C4=CC=NC(C)=C4)=N3.[H]Cl

Molecular Formula

C19H21ClN6O4

Molecular Weight

432.86

References & Citations

[1]JohnHynesJr, et al. Chapter Nine - Advances in the Discovery of Small-Molecule IRAK4 Inhibitors. Annu Rep Med Chem. 2014 (49) :117-133.|[2]Mitsuhiro Kondo, et al. Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats. Naunyn Schmiedebergs Arch Pharmacol. 2014 Oct;387 (10) :909-19.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

IRAK4

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CDC25A (M-phase Inducer Phosphatase 1, Dual Specificity Phosphatase Cdc25A) (MaxLight 405) discontinued
124734-ML405 100 µL

CDC25A (M-phase Inducer Phosphatase 1, Dual Specificity Phosphatase Cdc25A) (MaxLight 405) discontinued

Ask
View Details
OPSS-Val-Cit-PAB-OH
MF-0043030-01 100 mg

OPSS-Val-Cit-PAB-OH

Ask
View Details
OPSS-Val-Cit-PAB-OH
MF-0043030-02 500 mg

OPSS-Val-Cit-PAB-OH

Ask
View Details
Recombinant Human PARK7
MBS7613272-01 0.05 mg

Recombinant Human PARK7

Ask
View Details
Recombinant Human PARK7
MBS7613272-02 0.2 mg

Recombinant Human PARK7

Ask
View Details
Recombinant Human PARK7
MBS7613272-03 1 mg

Recombinant Human PARK7

Ask
View Details